Clinical Trial

Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to determine the impact of Pentoxifylline on inflammatory biomarkers and the progression of chronic kidney disease in non-diabetic patients.
Trial Details
NCT Number NCT07315139
Lead Sponsor Ain Shams University
Conditions Pentoxifylline, Inflammatory Markers, Non-Diabetic, Chronic Kidney Disease
Enrollment 42 participants
Start Date 2023-02-01
Primary Completion 2023-08-31 (estimated)
Study Completion 2023-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-02